LEADER 01645oam  2200433 a 450 
001 9910697748203321
005 20090506083654.0
035   $a(CKB)5470000002391491
035   $a(OCoLC)269009575
035   $a(EXLCZ)995470000002391491
100   $a20081105d2008      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEvaluating the propriety and adequacy of the Oxycontin criminal settlement$b[electronic resource] $ehearing before the Committee on the Judiciary, United States Senate, One Hundred Tenth Congress, first session, July 31, 2007
210  1$aWashington :$cU.S. G.P.O.,$d2008.
215   $aiv, 171 pages $cdigital, PDF file
225 1 $aS. hrg. ;$v110-479
300   $aTitle from title screen (viewed on Nov. 5, 2008).
300   $a"Serial no. J-110-50."
320   $aIncludes bibliographical references.
517   $aEvaluating the propriety and adequacy of the Oxycontin criminal settlement 
606   $aOxycodone$zUnited States
606   $aDrugs$xMarketing$xCorrupt practices$zUnited States
606   $aCriminal liability of juristic persons$zUnited States
606   $aMedication abuse$zUnited States
615  0$aOxycodone
615  0$aDrugs$xMarketing$xCorrupt practices
615  0$aCriminal liability of juristic persons
615  0$aMedication abuse
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910697748203321
996   $aEvaluating the propriety and adequacy of the Oxycontin criminal settlement$93483650
997   $aUNINA